Skip to main content
Premium Trial:

Request an Annual Quote

Gene Logic to Help Organon Revive Shelved Drug Candidates

NEW YORK, April 21 (GenomeWeb News) - Gene Logic and Organon have signed a drug-repositioning pact and plan to seek alternative paths for "multiple" drug candidates Organon had previously shelved.

 

As part of the agreement, if the research yields new uses for the candidates, the partners will become equal owners and may decide to jointly develop and commercialize the candidate. The companies did not disclose the indications they will be researching.

 

Gene Logic will receive a success-based milestone payment for each therapeutic candidate that Organon chooses to enter into clinical development, Gene Logic said.

The Scan

Study Finds Sorghum Genetic Loci Influencing Composition, Function of Human Gut Microbes

Focusing on microbes found in the human gut microbiome, researchers in Nature Communications identified 10 sorghum loci that appear to influence the microbial taxa or microbial metabolite features.

Treatment Costs May Not Coincide With R&D Investment, Study Suggests

Researchers in JAMA Network Open did not find an association between ultimate treatment costs and investments in a drug when they analyzed available data on 60 approved drugs.

Sleep-Related Variants Show Low Penetrance in Large Population Analysis

A limited number of variants had documented sleep effects in an investigation in PLOS Genetics of 10 genes with reported sleep ties in nearly 192,000 participants in four population studies.

Researchers Develop Polygenic Risk Scores for Dozens of Disease-Related Exposures

With genetic data from two large population cohorts and summary statistics from prior genome-wide association studies, researchers came up with 27 exposure polygenic risk scores in the American Journal of Human Genetics.